Tumor-infiltrating immune-cell abundances estimated with CIBERSORTx were cross-validated, either with immunohistochemistry (CD8+ T or NK cells) or with hematoxylin–eosin staining (eosinophils) in MCL cases representing high or low ratios of these cell types (Figure S5). Here, CD8A is linked to neoplasm.